Diabetic Medicine

The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy

https://dx.doi.org/10.1111/j.1464-5491.2006.02057.x

Post author By Currie C J, Poole C D, Woehl A, Morgan C L, Cawley S, Rousculp M D, Covington M T and Peters J R
Post date 26 January 2007

Currie C J, Poole C D, Woehl A, Morgan C L, Cawley S, Rousculp M D, Covington M T, Peters J R. 26 Jan 2007

Currie C J

Poole C D

Woehl A

Morgan C L

Cawley S

Rousculp M D

Covington M T

Peters J R

Transforming real-world data into transparent, reliable, and reliable real-world evidence

44 (0) 2920 782856

enquiries@humandatasciences.com

24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone® is a Trusted Research Environment (TRE)

Quick Links

Transforming real-world data into transparent, reliable, and replicable real-world evidence

44 (0) 2920 782856

instantRWE@humandatasciences.com

The Global Pharma Research Centre,
24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone^® is a Trusted Research Environment (TRE)

Web Design – Create Summit

Site by Create Summit